Literature DB >> 12031370

Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis.

A Tasca1, A Cacciola, P Ferrarese, E Ioverno, E Visonà, C Bernardi, M Nobile, S Giannini.   

Abstract

OBJECTIVES: To verify whether alterations in bone density and turnover in patients with calcium nephrolithiasis and hypercalciuria are observable in various subgroups of patients divided according to the pathogenesis of the hypercalciuria.
METHODS: Seventy patients with calcium nephrolithiasis and idiopathic hypercalciuria, 19 to 64 years old, were assessed for spine and femur mineral metabolism and bone density using a Dexa evaluation system. After a low calcium diet, the subjects were classified into two groups: fasting hypercalciuria (FH, 39 patients) and absorptive hypercalciuria (AH, 31 patients).
RESULTS: Only in the patients with FH was the lumbar spine bone density lower than in the controls (P <0.001). Also, only the patients with FH had higher bone alkaline phosphatase and urinary hydroxyproline levels than the control group (P <0.005 and <0.015, respectively). The blood pH levels were lower, even though within the normal range, in the hypercalciuric patients than in the controls (P <0.01). There was a negative correlation between the urinary hydroxyproline level and lumbar spine and femoral neck density in patients with FH (P <0.001 and <0.005, respectively), and the blood pH correlated positively with the lumbar spine bone density.
CONCLUSIONS: Altered bone metabolism and overall bone loss were found only in the patients with FH. Overloading of acid valences, perhaps of dietary origin, could be the pathogenic factor responsible.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031370     DOI: 10.1016/s0090-4295(02)01626-6

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  16 in total

1.  The expression and implication of TRPV5, Calbindin-D28k and NCX1 in idiopathic hypercalciuria.

Authors:  Shaogang Wang; Dongliang Hu; Qilin Xi; Shiqiang Su; Jian Bai; Jihong Liu; Zhangqun Ye
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

2.  Bisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug.

Authors:  Gerolamo Bianchi; Andrea Giusti; Giulio Pioli; Antonella Barone; Ernesto Palummeri; Giuseppe Girasole
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-02       Impact factor: 5.346

3.  Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria.

Authors:  Emmanuel Letavernier; Olivier Traxer; Michel Daudon; Mohammed Tligui; Jérôme Hubert-Brierre; Dominique Guerrot; Aline Sebag; Laurent Baud; Jean-Philippe Haymann
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

Review 4.  Idiopathic hypercalciuria and bone health.

Authors:  Laura E Ryan; Steven W Ing
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

Review 5.  Nephrolithiasis-associated bone disease: pathogenesis and treatment options.

Authors:  Khashayar Sakhaee; Naim M Maalouf; Rajiv Kumar; Andreas Pasch; Orson W Moe
Journal:  Kidney Int       Date:  2010-12-01       Impact factor: 10.612

6.  Is the fasting calcium/creatinine a bone resorption marker in patients with calcium renal stones?

Authors:  Miguel Angel Arrabal-Polo; Miguel Arrabal-Martin; Antonio Poyatos-Andujar; Encarnacion Cardenas-Grande; Sergio Merino-Salas; Armando Zuluaga-Gomez
Journal:  Urol Res       Date:  2011-12-04

7.  Bone disease in primary hypercalciuria.

Authors:  Stefania Sella; Catia Cattelan; Giuseppe Realdi; Sandro Giannini
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

8.  The relation between bone and stone formation.

Authors:  Nancy S Krieger; David A Bushinsky
Journal:  Calcif Tissue Int       Date:  2012-12-18       Impact factor: 4.333

Review 9.  Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat.

Authors:  Kevin K Frick; Nancy S Krieger; David A Bushinsky
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-07       Impact factor: 2.894

10.  Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia.

Authors:  S C Kaste; N A Thomas; S N Rai; K Cheon; E McCammon; R Chesney; D Jones; C-H Pui; M M Hudson
Journal:  Leukemia       Date:  2008-10-02       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.